Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Insulin on Protein Turnover in AKI
NCT00592410Phase 2Withdrawn
- Sponsor
- Vanderbilt University
- Start
- Feb 2007
- Primary completion
- Nov 2008
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 2, open-label trial of human insulin in acute kidney injury (AKI), sponsored by Vanderbilt University. Primary endpoint: Change in whole body and muscle protein breakdown at 6 hours. Planned start Feb 2007; status: withdrawn.
02
Drugs
human insulin
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT00592410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00592410.